Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
May 29, 2008
CEO presentation to AGM
May 26, 2008
Response to ASX Query re: Appendix 4C
May 15, 2008
Positive interim safety analysis for Glypromate
Apr 30, 2008
Appendix 4C - quarterly
Apr 29, 2008
Quarterly Update to Shareholders April 2008
Apr 29, 2008
Notice of Annual General Meeting/Proxy Form
Mar 31, 2008
Annual Report to shareholders
Mar 18, 2008
Co-CEOs remuneration packages
Feb 29, 2008
Appendix 4E Preliminary Final Report
Feb 26, 2008
Appendix 3B
Previous
1
2
3
4
5
6
Next